Mutation analysis of the PTEN/MMAC1 gene in lung cancer

Eva Forgacs, Eric J. Biesterveld, Yoshitaka Sekido, Kwun Fong, Sabeeha Muneer, Ignacio I. Wistuba, Sara Milchgrub, Ruth Brezinschek, Arvind Virmani, Adi F. Gazdar, John D. Minna

Research output: Contribution to journalArticle

179 Citations (Scopus)

Abstract

We studied PTEN/MMAC1, a newly discovered candidate tumor suppressor gene at 10q23.3, for mutations in lung cancer. One hundred and thirty-six lung cancer cell line DNAs (66 small cell lung cancers, SCLC, 61 non-small cell lung cancers, NSCLC, four mesotheliomas, five extrapulmonary small cell cancers) were analysed for PTEN/MMAC1 homozygous deletions and five (8%) SCLC lines showed homozygous deletions interrupting the PTEN/MMAC1 gene. Using single stranded conformation polymorphism (SSCP) analysis, we screened the PTEN/MMAC1 open reading frame of 53 lung cancer cell line cDNAs for point mutations and found that 3/35 SCLCs and 3/18 NSCLCs contained homozygous amino acid sequence altering mutations. Northern blot analysis revealed that expression of the PTEN/MMAC1 gene was considerably lower in all the tumor cell lines with point mutations while no expression was detected for cell lines with PTEN/MMAC1 homozygous deletions. Mutation analysis of 22 uncultured, microdissected, primary SCLC tumors and metastases showed two silent mutations, and two apparent homozygous deletions. We also discovered a processed pseudogene (PTEN2) which has 98.5% nt identity to PTEN/MMAC1, that needs to be accounted for in cDNA mutation analysis. Our findings suggest that genetic abnormalities of the PTEN/MMAC1 gene are only involved in a relatively small subset of lung cancers.

Original languageEnglish (US)
Pages (from-to)1557-1565
Number of pages9
JournalOncogene
Volume17
Issue number12
StatePublished - Sep 24 1998

Fingerprint

Lung Neoplasms
Mutation
Point Mutation
Cell Line
Genes
Complementary DNA
Pseudogenes
Mesothelioma
Small Cell Lung Carcinoma
Tumor Cell Line
Tumor Suppressor Genes
Non-Small Cell Lung Carcinoma
Northern Blotting
Open Reading Frames
Amino Acid Sequence
Neoplasms
Neoplasm Metastasis
DNA

Keywords

  • Chromosome 10q23
  • Homozygous deletion
  • Loss of heterozygosity

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Forgacs, E., Biesterveld, E. J., Sekido, Y., Fong, K., Muneer, S., Wistuba, I. I., ... Minna, J. D. (1998). Mutation analysis of the PTEN/MMAC1 gene in lung cancer. Oncogene, 17(12), 1557-1565.

Mutation analysis of the PTEN/MMAC1 gene in lung cancer. / Forgacs, Eva; Biesterveld, Eric J.; Sekido, Yoshitaka; Fong, Kwun; Muneer, Sabeeha; Wistuba, Ignacio I.; Milchgrub, Sara; Brezinschek, Ruth; Virmani, Arvind; Gazdar, Adi F.; Minna, John D.

In: Oncogene, Vol. 17, No. 12, 24.09.1998, p. 1557-1565.

Research output: Contribution to journalArticle

Forgacs, E, Biesterveld, EJ, Sekido, Y, Fong, K, Muneer, S, Wistuba, II, Milchgrub, S, Brezinschek, R, Virmani, A, Gazdar, AF & Minna, JD 1998, 'Mutation analysis of the PTEN/MMAC1 gene in lung cancer', Oncogene, vol. 17, no. 12, pp. 1557-1565.
Forgacs E, Biesterveld EJ, Sekido Y, Fong K, Muneer S, Wistuba II et al. Mutation analysis of the PTEN/MMAC1 gene in lung cancer. Oncogene. 1998 Sep 24;17(12):1557-1565.
Forgacs, Eva ; Biesterveld, Eric J. ; Sekido, Yoshitaka ; Fong, Kwun ; Muneer, Sabeeha ; Wistuba, Ignacio I. ; Milchgrub, Sara ; Brezinschek, Ruth ; Virmani, Arvind ; Gazdar, Adi F. ; Minna, John D. / Mutation analysis of the PTEN/MMAC1 gene in lung cancer. In: Oncogene. 1998 ; Vol. 17, No. 12. pp. 1557-1565.
@article{feae5c7182ba4e9e84042457b278343d,
title = "Mutation analysis of the PTEN/MMAC1 gene in lung cancer",
abstract = "We studied PTEN/MMAC1, a newly discovered candidate tumor suppressor gene at 10q23.3, for mutations in lung cancer. One hundred and thirty-six lung cancer cell line DNAs (66 small cell lung cancers, SCLC, 61 non-small cell lung cancers, NSCLC, four mesotheliomas, five extrapulmonary small cell cancers) were analysed for PTEN/MMAC1 homozygous deletions and five (8{\%}) SCLC lines showed homozygous deletions interrupting the PTEN/MMAC1 gene. Using single stranded conformation polymorphism (SSCP) analysis, we screened the PTEN/MMAC1 open reading frame of 53 lung cancer cell line cDNAs for point mutations and found that 3/35 SCLCs and 3/18 NSCLCs contained homozygous amino acid sequence altering mutations. Northern blot analysis revealed that expression of the PTEN/MMAC1 gene was considerably lower in all the tumor cell lines with point mutations while no expression was detected for cell lines with PTEN/MMAC1 homozygous deletions. Mutation analysis of 22 uncultured, microdissected, primary SCLC tumors and metastases showed two silent mutations, and two apparent homozygous deletions. We also discovered a processed pseudogene (PTEN2) which has 98.5{\%} nt identity to PTEN/MMAC1, that needs to be accounted for in cDNA mutation analysis. Our findings suggest that genetic abnormalities of the PTEN/MMAC1 gene are only involved in a relatively small subset of lung cancers.",
keywords = "Chromosome 10q23, Homozygous deletion, Loss of heterozygosity",
author = "Eva Forgacs and Biesterveld, {Eric J.} and Yoshitaka Sekido and Kwun Fong and Sabeeha Muneer and Wistuba, {Ignacio I.} and Sara Milchgrub and Ruth Brezinschek and Arvind Virmani and Gazdar, {Adi F.} and Minna, {John D.}",
year = "1998",
month = "9",
day = "24",
language = "English (US)",
volume = "17",
pages = "1557--1565",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Mutation analysis of the PTEN/MMAC1 gene in lung cancer

AU - Forgacs, Eva

AU - Biesterveld, Eric J.

AU - Sekido, Yoshitaka

AU - Fong, Kwun

AU - Muneer, Sabeeha

AU - Wistuba, Ignacio I.

AU - Milchgrub, Sara

AU - Brezinschek, Ruth

AU - Virmani, Arvind

AU - Gazdar, Adi F.

AU - Minna, John D.

PY - 1998/9/24

Y1 - 1998/9/24

N2 - We studied PTEN/MMAC1, a newly discovered candidate tumor suppressor gene at 10q23.3, for mutations in lung cancer. One hundred and thirty-six lung cancer cell line DNAs (66 small cell lung cancers, SCLC, 61 non-small cell lung cancers, NSCLC, four mesotheliomas, five extrapulmonary small cell cancers) were analysed for PTEN/MMAC1 homozygous deletions and five (8%) SCLC lines showed homozygous deletions interrupting the PTEN/MMAC1 gene. Using single stranded conformation polymorphism (SSCP) analysis, we screened the PTEN/MMAC1 open reading frame of 53 lung cancer cell line cDNAs for point mutations and found that 3/35 SCLCs and 3/18 NSCLCs contained homozygous amino acid sequence altering mutations. Northern blot analysis revealed that expression of the PTEN/MMAC1 gene was considerably lower in all the tumor cell lines with point mutations while no expression was detected for cell lines with PTEN/MMAC1 homozygous deletions. Mutation analysis of 22 uncultured, microdissected, primary SCLC tumors and metastases showed two silent mutations, and two apparent homozygous deletions. We also discovered a processed pseudogene (PTEN2) which has 98.5% nt identity to PTEN/MMAC1, that needs to be accounted for in cDNA mutation analysis. Our findings suggest that genetic abnormalities of the PTEN/MMAC1 gene are only involved in a relatively small subset of lung cancers.

AB - We studied PTEN/MMAC1, a newly discovered candidate tumor suppressor gene at 10q23.3, for mutations in lung cancer. One hundred and thirty-six lung cancer cell line DNAs (66 small cell lung cancers, SCLC, 61 non-small cell lung cancers, NSCLC, four mesotheliomas, five extrapulmonary small cell cancers) were analysed for PTEN/MMAC1 homozygous deletions and five (8%) SCLC lines showed homozygous deletions interrupting the PTEN/MMAC1 gene. Using single stranded conformation polymorphism (SSCP) analysis, we screened the PTEN/MMAC1 open reading frame of 53 lung cancer cell line cDNAs for point mutations and found that 3/35 SCLCs and 3/18 NSCLCs contained homozygous amino acid sequence altering mutations. Northern blot analysis revealed that expression of the PTEN/MMAC1 gene was considerably lower in all the tumor cell lines with point mutations while no expression was detected for cell lines with PTEN/MMAC1 homozygous deletions. Mutation analysis of 22 uncultured, microdissected, primary SCLC tumors and metastases showed two silent mutations, and two apparent homozygous deletions. We also discovered a processed pseudogene (PTEN2) which has 98.5% nt identity to PTEN/MMAC1, that needs to be accounted for in cDNA mutation analysis. Our findings suggest that genetic abnormalities of the PTEN/MMAC1 gene are only involved in a relatively small subset of lung cancers.

KW - Chromosome 10q23

KW - Homozygous deletion

KW - Loss of heterozygosity

UR - http://www.scopus.com/inward/record.url?scp=7844247587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7844247587&partnerID=8YFLogxK

M3 - Article

C2 - 9794233

AN - SCOPUS:7844247587

VL - 17

SP - 1557

EP - 1565

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 12

ER -